CERO THERAPEUTICS HOLDINGS I (CERO)
US71902K1051 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash | 97.00K | 476.00K | 1.10M | |||
| Other Current Assets | 8.46M | 41.89M | 263.00K | |||
| Total Current Assets | 8.56M | 42.37M | 1.36M | |||
| Non-Current Assets | ||||||
| Investments And Advances | N/A | 0.00 | 178.50M | |||
| Other Non-Current Assets | N/A | 0.00 | 218.00K | |||
| Total Non-Current Assets | 0.00 | 0.00 | 178.72M | |||
| TOTAL ASSETS | 8.56M | 42.37M | 180.08M | |||
| LIABILITIES | ||||||
| Current Liabilities | ||||||
| Short Term Debt | 1.55M | 650.00K | 0.00 | |||
| Accrued Expenses | 56.00K | 0.00 | 80.00K | |||
| Accounts Payable | 3.54M | 1.65M | 14.00K | |||
| Other Current Liabilities | 27.00K | 28.45M | 3.00K | |||
| Total Current Liabilities | 5.17M | 30.75M | 98.00K | |||
| Non-Current Liabilities | ||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 9.15M | 9.15M | 9.15M | |||
| Total Non-Current Liabilities | 9.15M | 9.15M | 9.15M | |||
| TOTAL LIABILITIES | 14.32M | 39.90M | 9.25M | |||
| SHAREHOLDERS' EQUITY | ||||||
| Retained Earnings | -14.20M | -10.76M | -7.67M | |||
| Additional Paid In Capital | N/A | 0.00 | 0.00 | |||
| Common Shares | 8.44M | 13.22M | 178.50M | |||
| Shares Outstanding | 6.25M | 6.77M | 22.98M | |||
| Tangible Book Value per Share | -0.92 | 0.36 | 7.43 | |||
| Total Shareholders' Equity | -5.76M | 2.47M | 170.83M | |||
| TOTAL LIABILITIES AND EQUITY | 8.56M | 42.37M | 180.08M | |||
| Statistics | ||||||
| Current Ratio | 1.65 | 1.38 | 13.89 | |||
| Return On Assets (ROA) | -29.63% | -1.58% | -0.18% | |||
| Return On Equity (ROE) | N/A | -27.04% | -0.18% | |||
All data in USD , ROIC based on taxRate of 0.21